This presentation explores the financial and operational challenges shaping biopharma in 2025, from frozen IPO markets and funding volatility to regulatory scrutiny and commercial pressures. Drawing on Auxilius’ benchmarking survey and industry data, it outlines how finance leaders can navigate capital scarcity, improve visibility into R&D spend, and build more resilient forecasting and controls to drive strategic advantage.
.png)
